Idarucizumab, an investigational drug, rapidly and completely neutralizes the anticoagulant activity of dabigatran in most patients who have serious bleeding or require an urgent procedure, according ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback